Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-154-7 | CAS number: 2374-14-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Absorption rate - dermal (%):
- 0.098
Additional information
There are no in vivo data on the toxicokinetics of 2,4,6 -trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane (F-D3), although an in vitro dermal penetration study is available.
The following summary has therefore been prepared based on validated predictions of the physicochemical properties of the substance itself and its hydrolysis products and using this data in algorithms that are the basis of many computer-based physiologically based pharmacokinetic or toxicokinetic (PBTK) prediction models. Although these algorithms provide a numerical value, for the purposes of this summary only qualitative statements or predictions will be made.
The main input variable for the majority of these algorithms is log Kow so by using this, and other where appropriate, known or predicted physicochemical properties of 2,4,6 -trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane or its hydrolysis products, reasonable predictions or statements may be made about their potential absorption, distribution, metabolism and excretions (ADME) properties.
Hydrolysis half-lives of >7.5 days at pH 5, 6 days at pH 7 and 11 minutes at pH 9 and 25°C were determined for F-D3. The half-lives described are for the removal of parent substance. Complete reaction to the ultimate end products would take longer.1,5-Dihydroxy-1,3,5-trimethyl-1,3,5-tris(3,3,3-trifluoropropyl)trisiloxane and 3,3,3-trifluoropropylmethysilanediol are the postulated intermediate and final hydrolysis products respectively.
Human exposure can occur via the inhalation or dermal routes.
Absorption
Oral
Significant oral exposure is not expected for F-D3.
When oral exposure takes place, it is necessary to assume that except for the most extreme of insoluble substances, that uptake through intestinal walls into the blood takes place. Uptake from intestines can be assumed to be possible for all substances that have appreciable solubility in water or lipid. Other mechanisms by which substances can be absorbed in the gastrointestinal tract include the passage of small water-soluble molecules (molecular weight up to around 200) through aqueous pores or carriage of such molecules across membranes with the bulk passage of water (Renwick, 1993).
With a molecular weight of 468.5 and a water solubility of 1.3E-06 mg/l virtually no systemic exposure to F-D3 would be expected following oral exposure. However, in an oral acute (TNO, 1986) and repeat dose (Dow Corning Corporation, 2002a) studies there were signs of systemic toxicity indicating absorption of test substance-related material had occurred (parent substance or metabolites/hydrolysis products of the test substance).
Dermal
In an in vitro dermal penetration study using 14C-F-D3 conducted to a design comparable to OECD 428 and in compliance with GLP (Dow Corning, 2015), only 0.098% of the applied dose was found to penetrate through rabbit skin. Only 0.629% of the applied dose volatilised, meaning the majority of the applied dose, remained either in or on the skin.
The fat solubility and therefore potential dermal penetration of a substance can be estimated by using the water solubility and log Kow values. Substances with log Kow values between 1 and 4 favour dermal absorption (values between 2 and 3 are optimal) particularly if water solubility is high.
The water solubility (1.3E-06 mg/l) and predicted log Kow (9.0) of the parent substance, F-D3, are far from favourable for absorption across the skin. The predicted dermal absorption for the parent substance is therefore consistent with the data from the in vitro study. However, systemic toxicity was observed in rabbit acute (Cannon Labs, 1979) and repeat dose dermal toxicity (Siddiqui and Hobbs, 1982) studies indicates absorption of test substance-related material had occurred (parent substance or metabolites/hydrolysis products of the test substance).
Inhalation
There is a QSPR to estimate the blood:air partition coefficient for human subjects as published by Meulenberg and Vijverberg (2000). The resulting algorithm uses the dimensionless Henry coefficient and the octanol:air partition coefficient (Koct:air) as independent variables.
Using these values for F-D3 results in an extremely lowblood:air partition coefficient of approximately 7.2E-08:1, meaning that even if lung exposure occurred there would be no uptake into the systemic circulation.
No signs of systemic toxicity were reported in an acute inhalation study.
Distribution
Absorbed test substance may be in the form of the parent substance, the intermediate hydrolysis product, 1,5 -dihydroxy-1,3,5-trimethyl-1,3,5-tris(3,3,3-trifluoropropyl)trisiloxane or the final hydrolysis product, 3,3,3-trifluoropropylmethysilanediol.
For blood:tissue partitioning a QSPR algorithm has been developed by DeJongh et al. (1997) in which the distribution of compounds between blood and human body tissues as a function of water and lipid content of tissues and the n-octanol:water partition coefficient (Kow) is described.
Using this value for F-D3 predicts that, should systemic exposure occur, potential distribution into the main body compartments would be primarily into the lipid compartment, and to a lesser extent to the other tissues.
Table 5.1.1: tissue:blood partition coefficients
|
Log Kow |
Kow |
Liver |
Muscle |
Fat |
Brain |
Kidney |
F-D3 |
9.0 |
1.00E+09 |
8.9 |
5.5 |
113.9 |
20.5 |
8.4 |
Metabolism
There are no data regarding the metabolism of 2,4,6 -trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane. Genetic toxicity tests in vitro showed no observable differences in effects with and without metabolic activation.
Excretion
A determinant of the extent of urinary excretion is the soluble fraction in blood. QPSR’s as developed by DeJongh et al. (1997) using log Kow as an input parameter, calculate the solubility in blood based on lipid fractions in the blood assuming that human blood contains 0.7% lipids.
Using this algorithm, the soluble fraction of the parent F-D3 is <0.001% meaning that it is unlikely to be eliminated via the kidneys.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.